| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |